PFE Receives FDA Approval
Pfizer's Palbociclib in combination with Trastuzumab receives FDA approval for treatment of metastatic breast cancer
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Pfizer's Palbociclib in combination with Trastuzumab receives FDA approval for treatment of metastatic breast cancer